These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34738432)
1. [Dryness comparison of different fractions of Aurantii Fructus extract on normal mice and gastrointestinal motility disorder rats and spectrum-dryness study]. Qiao RF; Zhong MY; Zhang M; Yang L; DU XQ; Tuo FL; Yuan JB Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5291-5303. PubMed ID: 34738432 [TBL] [Abstract][Full Text] [Related]
2. Spectrum-effect relationship between UHPLC-Q-TOF/MS fingerprint and promoting gastrointestinal motility activity of Fructus aurantii based on multivariate statistical analysis. Qiao R; Zhou L; Zhong M; Zhang M; Yang L; Yang Y; Chen H; Yang W; Yuan J J Ethnopharmacol; 2021 Oct; 279():114366. PubMed ID: 34181960 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of Fructus Aurantii Flavonoids Promoting Gastrointestinal Motility: From Organic and Inorganic Endogenous Substances Combination Point of View. Wang S; Bao YR; Li TJ; Yu T; Chang X; Yang GL; Meng XS Pharmacogn Mag; 2017; 13(51):372-377. PubMed ID: 28839359 [TBL] [Abstract][Full Text] [Related]
4. [Chemical variation in Aurantii Fructus before and after processing based on UHPLC-Q-TOF-MS]. Cheung TK; Li W; Ho HM; Liang ZT; Huang CQ Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(11):2070-2080. PubMed ID: 28901103 [TBL] [Abstract][Full Text] [Related]
5. [Dryness-alleviating effect of processed Aurantii Fructus from Lingnan based on correlation of fecal metabolomics and dryness]. Huang YY; Yang T; Wang QQ; Long JL; Li QR; Xu QJ; Huang AH; Wang JY; Xia Q Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):82-95. PubMed ID: 36725261 [TBL] [Abstract][Full Text] [Related]
6. The influence of compatibility of traditional Chinese medicine on the pharmacokinetic of main components in Fructus aurantii. Zhang J; Gao W; Hu X; Liu Z; Liu C J Ethnopharmacol; 2012 Nov; 144(2):277-83. PubMed ID: 23000113 [TBL] [Abstract][Full Text] [Related]
7. The effects of Fructus Aurantii extract on the 5-hydroxytryptamine and vasoactive intestinal peptide contents of the rat gastrointestinal tract. Jiang Y; Bai X; Zhu X; Li J Pharm Biol; 2014 May; 52(5):581-5. PubMed ID: 24707973 [TBL] [Abstract][Full Text] [Related]
8. Study on spectrum-effect relationship of rhizoma Rhei, cortex Magnoliae Officinalis, fructus Aurantii Immaturus and their formula. Xie RF; Zhou X; Shi ZN; Li YM; Li ZC J Chromatogr Sci; 2013 Jul; 51(6):524-32. PubMed ID: 23118210 [TBL] [Abstract][Full Text] [Related]
9. [Suitable harvest period of Aurantii Fructus based on UPLC-Q-TOF-MS metabolomics]. Wang H; Huang YS; Liang YQ; Zhang XY; Xie H; Zhang SW Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3175-3184. PubMed ID: 35851109 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous Quantification of Five Flavanone Glycosides in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry: Application to a Comparative Pharmacokinetic Study of Aurantii Fructus Immaturus and Aurantii Fructus Extracts. Li P; Zeng SL; Wang ZY; Yin Q; Bi ZM; Liu EH J AOAC Int; 2019 May; 102(3):781-787. PubMed ID: 30563590 [No Abstract] [Full Text] [Related]
11. Comparison of the chemical constituents of raw Fructus Aurantii and Fructus Aurantii stir-baked with bran, and the biological effects of auraptene. Li YG; Wang XY; Chen HF; Yuan JB; Meng Y; Yang WL J Ethnopharmacol; 2021 Apr; 269():113721. PubMed ID: 33359001 [TBL] [Abstract][Full Text] [Related]
12. Identification of chemical constituents in extracts and rat plasma from Fructus Aurantii by UPLC-PDA-Q-TOF/MS. Ma C; Gao W; Gao Y; Man S; Huang L; Liu C Phytochem Anal; 2011; 22(2):112-8. PubMed ID: 21259373 [TBL] [Abstract][Full Text] [Related]
13. [Comparison between peel and pulp of Aurantii Fructus Immaturus by UPLC fingerprint and multicomponent quantitative analysis]. Shi JY; Cai WJ; Lin WD; Zhang S; Luo R Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4446-4455. PubMed ID: 34581049 [TBL] [Abstract][Full Text] [Related]
14. The Effects of Low-Dose and High-Dose Decoctions of Fructus aurantii in a Rat Model of Functional Dyspepsia. Zhu J; Tong H; Ye X; Zhang J; Huang Y; Yang M; Zhong L; Gong Q Med Sci Monit; 2020 Apr; 26():e919815. PubMed ID: 32248203 [TBL] [Abstract][Full Text] [Related]
15. Analysis of quality evaluation and optimal harvest period of Aurantii Fructus from different sources using UHPLC-Q-TOF-MS/MS. Liu ZX; Wang L; Fu XS; Long YQ; Zeng J; Chen GY; Zhou RB; Liu XD Phytochem Anal; 2024 Jul; 35(5):1221-1248. PubMed ID: 38639073 [TBL] [Abstract][Full Text] [Related]
16. [Study and comparison on HPLC fingerprints of flavonoids of frequently used Chinese materia medica in citrus]. Chen Y; Lin L Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2660-5. PubMed ID: 22242425 [TBL] [Abstract][Full Text] [Related]
17. [Three-dimensional multi-component analysis of Aurantii Fructus quality and research on influencing factors]. Liu ZX; Fu XS; Wang L; Liu XD; Zhou RB Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):265-272. PubMed ID: 36725279 [TBL] [Abstract][Full Text] [Related]
18. Integrated UPLC/Q-TOF-MS/MS Analysis and Network Pharmacology to Reveal the Neuroprotective Mechanisms and Potential Pharmacological Ingredients of Aurantii Fructus Immaturus and Aurantii Fructus. Qiu M; Zhang J; Wei W; Zhang Y; Li M; Bai Y; Wang H; Meng Q; Guo DA Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399454 [TBL] [Abstract][Full Text] [Related]
19. Identification and Comparison of Constituents of Aurantii Fructus and Aurantii Fructus Immaturus by UFLC-DAD-Triple TOF-MS/MS. Bai Y; Zheng Y; Pang W; Peng W; Wu H; Yao H; Li P; Deng W; Cheng J; Su W Molecules; 2018 Mar; 23(4):. PubMed ID: 29601542 [TBL] [Abstract][Full Text] [Related]
20. [Study on Genuineness Recognition of "Jiang Aurantii Fructus" by Analyzing Fingerprint Similarity Using Information Entropy Theory]. Wu L; Yang HS Zhong Yao Cai; 2015 Jun; 38(6):1180-2. PubMed ID: 26762057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]